In vivo selection for corrected β-globin alleles after CRISPR/Cas9 editing in human sickle hematopoietic stem cells enhances therapeutic potential. Magis, W., Dewitt, M., Wyman, S. K., Vu, J. T., Heo, S., Shao, S., Hennig, F., Romero, Z., Campo-Fernandez, B., McNeill, M., Rettig, G. R., Sun, Y., Lau, P. J., Wang, Y., Behlke, M. A., Kohn, D. B., Boffelli, D., Walters, M. C., Corn, J. E., & Martin, D. I. K. 2018.
bibtex   
@article{1987,
  author = {Wendy Magis and Mark Dewitt and Stacia K. Wyman and Jonathan T. Vu and Seongkook Heo and Shirley Shao and Fiona Hennig and Zulema Romero and Beatriz Campo-Fernandez and Matthew McNeill and Garrett R. Rettig and Yongming Sun and Patrick J. Lau and Yu Wang and Mark A. Behlke and Donald B. Kohn and Dario Boffelli and Mark C. Walters and Jacob E. Corn and David I. K. Martin},
  title = {In vivo selection for corrected β-globin alleles after CRISPR/Cas9 editing in human sickle hematopoietic stem cells enhances therapeutic potential},
  year = {2018}
}

Downloads: 0